Back to results
US 11,530,198 B2Granted
Compositions and methods for treating infections
AssigneeVyera Pharmaceuticals, LLC
InventorsStephen B. Thomas, Allen T. Hopper, Matthew Welsch
Life of this patent
Estimating the term…
Abstract
The invention relates to inhibitors of dihydrofolate reductase and pharmaceutical preparations thereof. The invention further relates to methods of treatment of parasitic infections, such as T. gondii, T. cruzi, P. falciparum, T. brucei, or L. major infections, using the novel inhibitors of the invention.
Claims18
A method of treating a protozoan infection, comprising administering to a patient in need thereof a compound having the structure of formula (I), a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or salt:
- wherein:
- R1 is H, C1-6 alkyl, C3-6 cycloalkyl, C4-8 cycloalkylalkyl, or halogen;
- W is N or CR18 and Z is N or CR17, provided that at least one of W and Z is N;
- R2, R3, R4, R5, R6, R7, R8, R9, R17, and R18 are independently selected from H, C1-6 alkyl, C3-6 cycloalkyl, hydroxyl and fluorine;
- provided that at least four of R2, R3, R4, R5, R6, R7, R8, and R9 are H;
- if W is N, then none of R2, R3, R6, and R7 is hydroxyl;
- and if Z is N, then none of R4, R5, R8, and R9 is hydroxyl;
- and
- R10 is substituted or unsubstituted C6-10 aryl or 5- to 10-membered heteroaryl,
- wherein the infection is caused by an Apicomplexan protozoan, wherein the genus of the protozoan is selected from Toxoplasma, Leishmania, and Trypanosoma.
7 more elements
Dependencies are inferred from the claim text.